1. Home
  2. PGEN vs OBK Comparison

PGEN vs OBK Comparison

Compare PGEN & OBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.12

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Origin Bancorp Inc.

OBK

Origin Bancorp Inc.

HOLD

Current Price

$46.16

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
OBK
Founded
1998
1912
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
PGEN
OBK
Price
$4.12
$46.16
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$8.33
$46.67
AVG Volume (30 Days)
2.8M
184.4K
Earning Date
05-13-2026
04-22-2026
Dividend Yield
N/A
2.13%
EPS Growth
N/A
N/A
EPS
N/A
2.40
Revenue
$230,981,000.00
N/A
Revenue This Year
$1,115.92
$26.43
Revenue Next Year
$81.04
$5.79
P/E Ratio
N/A
$19.74
Revenue Growth
N/A
N/A
52 Week Low
$1.23
$32.13
52 Week High
$5.47
$48.12

Technical Indicators

Market Signals
Indicator
PGEN
OBK
Relative Strength Index (RSI) 54.94 58.25
Support Level $3.91 $34.78
Resistance Level $4.31 N/A
Average True Range (ATR) 0.19 1.19
MACD 0.00 0.01
Stochastic Oscillator 64.01 51.00

Price Performance

Historical Comparison
PGEN
OBK

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About OBK Origin Bancorp Inc.

Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.

Share on Social Networks: